Deplatt Clopidogrel 75mg Antiplatelet Cardiovascular Protection Tablets 30s

• Deplatt 75mg Tablets – clopidogrel bisulfate 75mg film-coated tablets (30 tablets) • Potent antiplatelet (P2Y12 inhibitor) – prevents blood clots in arteries • First-line therapy after heart attack, ischemic stroke, acute coronary syndrome (ACS), or coronary stent placement • Once-daily maintenance dose – reduces risk of future heart attack/stroke by ~20–25% • Prescription medicine – generic equivalent to original Plavix • 30-tablet pack = standard 1-month supply

Deplatt 75mg contains clopidogrel, the world’s most prescribed antiplatelet after aspirin. It irreversibly blocks the P2Y12 ADP receptor on platelets, preventing aggregation for the platelet’s lifespan (~7–10 days). Landmark trials (CAPRIE, CURE, COMMIT, CLARITY, TRITON) proved it superior to aspirin alone and essential in dual antiplatelet therapy (DAPT) with aspirin post-stent or ACS. Standard loading dose 300–600mg, then 75mg once daily long-term (often lifelong after stent). Benefits • Reduces risk of stent thrombosis, heart attack & stroke • Proven life-saving in acute coronary syndrome & post-PCI patients • Once-daily dosing – no timing restrictions with food • Film-coated tablet – easy to swallow • Cost-effective generic (up to 90% cheaper than original Plavix) • 30-tablet blister – convenient monthly pack • Safe for long-term use (years) in most patients How to Use • Adults: 75mg once daily (morning or evening) with or without food • Often combined with low-dose aspirin (75–100mg) as DAPT • Swallow whole – do not crush or chew • Continue indefinitely unless advised by cardiologist • Regular follow-up & bleeding risk monitoring • Store below 25°C in original packaging